Update on Immune Checkpoint Inhibitor Enterocolitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Update on Immune Checkpoint Inhibitor Enterocolitis

Published:2022-10-20 Issue:12 Volume:24 Page:171-181
ISSN:1522-8037
Container-title:Current Gastroenterology Reports
language:en
Short-container-title:Curr Gastroenterol Rep

Author:

Kelly-Goss Molly R.,Badran Yousef R.,Dougan Michael

Funder

National Institute of Allergy and Infectious Diseases

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11894-022-00852-7.pdf

Reference95 articles.

1. Baumeister SH, Freeman GJ, Dranoff G, Sharpe AH. Coinhibitory pathways in immunotherapy for cancer. Annu Rev Immunol. 2016;34(1):539–73. https://doi.org/10.1146/annurev-immunol-032414-112049.

2. Dougan M, Dranoff G, Dougan SK. Cancer immunotherapy: Beyond checkpoint blockade. Annu Rev Cancer Biol. 2019;3(1):55–75. https://doi.org/10.1146/annurev-cancerbio-030518-055552.

3. Hodi FS, O’Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8):711–23. https://doi.org/10.1056/NEJMoa1003466.

4. Robert C, Thomas L, Bondarenko I, et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med. 2011;364(26):2517–26. https://doi.org/10.1056/NEJMoa1104621.

5. Carbone DP, Reck M, Paz-Ares L, et al. First-line nivolumab in stage IV or recurrent non-small-cell lung cancer. N Engl J Med. 2017;376(25):2415–26. https://doi.org/10.1056/NEJMoa1613493.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of microparticles vaccine with MSI-1436 exerts a strong immune response for hepatocellular carcinoma;Journal of Leukocyte Biology;2024-07-16

2. Genetic similarity between relatives provides evidence on the presence and history of assortative mating;Nature Communications;2024-03-26

3. Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis;Nature Communications;2024-03-26

4. Colitis due to cancer treatment with immune check-point inhibitors – review of literature and presentation of clinical cases;Radiology and Oncology;2024-03-22

5. The evolving landscape of immune‐related adverse events that follow immune checkpoint immunotherapy in cancer patients;Immunological Reviews;2023-08-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3